Skip to content

Study about the usability of SMT-0094

Study about the usability of SMT-0094

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1080225023
Enrollment
4
Registered
2020-01-20
Start date
2020-01-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : SMT-0094 INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : Instillation

Sponsors

Senju Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Person who has given written informed consent 2) Person who usually use eye drops for general use

Exclusion criteria

Exclusion criteria: 1) Person with eye disease

Design outcomes

Primary

MeasureTime frame
other 1) Cool feeling 2) Moist feeling

Secondary

MeasureTime frame
other -

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026